Cytosolic phospholipase A2 regulates lipid homeostasis under osmotic stress through PPARγ

被引:2
|
作者
Parra, Leandro Gaston [1 ,2 ]
Erjavec, Luciana Cecilia [1 ,2 ]
Casali, Cecilia Irene [1 ,2 ]
Zerpa Velazquez, Andrea [1 ]
Weber, Karen [1 ]
Setton-Avruj, Clara Patricia [2 ,3 ]
Fernandez Tome, Maria del Carmen [1 ,2 ,4 ]
机构
[1] Univ Buenos Aires, Fac Farm & Bioquim, Dept Ciencias Biol, Catedra Biol Celular & Mol, Buenos Aires, Argentina
[2] Consejo Nacl Invest Cient & Tecn, Fac Farm & Bioquim, Inst Quim & Fisicoquim Biol Prof Dr Alejandro C Pa, Buenos Aires, Argentina
[3] Univ Buenos Aires, Fac Farm & Bioquim, Dept Quim Biol, Catedra Quim Biol Patol, Buenos Aires, Argentina
[4] UBA, Fac Farm & Bioquım, Dept Ciencias Biol Biol Celular & Mol, QUIFIB,CONICET, Junin 956,1er Piso,C1113AAD, Buenos Aires, Argentina
关键词
arachidonic acid; cytosolic phospholipase A(2); membrane homeostasis; peroxisomal proliferator activated receptor gamma; triglyceride synthesis; FLUID-MOSAIC MODEL; ARACHIDONIC-ACID; TRANSCRIPTION FACTORS; RENAL MEDULLA; BIOSYNTHESIS; METABOLISM; EXPRESSION; MEMBRANE; ENZYMES; ACTIVATION;
D O I
10.1111/febs.16998
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Physiologically, renal medullary cells are surrounded by a hyperosmolar interstitium. However, different pathological situations can induce abrupt changes in environmental osmolality, causing cell stress. Therefore, renal cells must adapt to survive in this new condition. We previously demonstrated that, among the mechanisms involved in osmoprotection, renal cells upregulate triglyceride biosynthesis (which helps preserve glycerophospholipid synthesis and membrane homeostasis) and cyclooxygenase-2 (which generates prostaglandins from arachidonic acid) to maintain lipid metabolism in renal tissue. Herein, we evaluated whether hyperosmolality modulates phospholipase A(2) (PLA(2)) activity, leading to arachidonic acid release from membrane glycerophospholipid, and investigated its possible role in hyperosmolality-induced triglyceride synthesis and accumulation. We found that hyperosmolality induced PLA(2) expression and activity in Madin-Darby canine kidney cells. Cytosolic PLA(2) (cPLA2) inhibition, but not secreted or calcium-independent PLA(2) (sPLA(2) or iPLA(2), respectively), prevented triglyceride synthesis and reduced cell survival. Inhibition of prostaglandin synthesis with indomethacin not only failed to prevent hyperosmolality-induced triglyceride synthesis but also exacerbated it. Similar results were observed with the peroxisomal proliferator activated receptor gamma (PPAR gamma) agonist rosiglitazone. Furthermore, hyperosmolality increased free intracellular arachidonic acid levels, which were even higher when prostaglandin synthesis was inhibited by indomethacin. Blocking PPAR gamma with GW-9662 prevented the effects of both indomethacin and rosiglitazone on triglyceride synthesis and even reduced hyperosmolality-induced triglyceride synthesis, suggesting that arachidonic acid may stimulate triglyceride synthesis through PPAR gamma activation. These results highlight the role of cPLA(2) in osmoprotection, since it is essential to provide arachidonic acid, which is involved in PPAR gamma-regulated triglyceride synthesis, thus guaranteeing cell survival.
引用
收藏
页码:722 / 743
页数:22
相关论文
共 50 条
  • [42] The investigation of cytosolic phospholipase A2 using ELISA
    Macdonald, DJ
    Boyle, RM
    Glen, ACA
    Ross, BM
    Glen, AIM
    Ward, PE
    McKinney, SB
    Peterkin, MA
    PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2004, 70 (04): : 377 - 381
  • [43] Lactosylceramide Interacts with and Activates Cytosolic Phospholipase A2α
    Nakamura, Hiroyuki
    Moriyama, Yuta
    Makiyama, Tomohiko
    Emori, Shunsuke
    Yamashita, Hisahiro
    Yamazaki, Risa
    Murayama, Toshihiko
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (32) : 23264 - 23272
  • [44] Localization and function of cytosolic phospholipase A2α at the Golgi
    Leslie, Christina C.
    Gangelhoff, Todd A.
    Gelb, Michael H.
    BIOCHIMIE, 2010, 92 (06) : 620 - 626
  • [45] Regulation of cytosolic phospholipase A2 activity by sphingolipids
    Shimizu, M
    Matsumoto, Y
    Hirabayashi, T
    Murayama, T
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2005, 97 : 144P - 144P
  • [46] Cytosolic phospholipase A2 as a target for drug design
    Lehr, M
    DRUGS OF THE FUTURE, 2000, 25 (08) : 823 - 832
  • [47] Cytosolic phospholipase A2 as a mediator of disease pathogenesis
    Linkous, Amanda
    Yazlovitskaya, Eugenia
    CELLULAR MICROBIOLOGY, 2010, 12 (10) : 1369 - 1377
  • [48] The role of cytosolic phospholipase A2 in insulin secretion
    Jones, PM
    Burns, CJ
    Belin, VD
    Roderigo-Milne, HM
    Persaud, SJ
    DIABETES, 2004, 53 : S172 - S178
  • [49] Increased levels of cytosolic phospholipase A2 in dyslexics
    MacDonnell, LEF
    Skinner, FK
    Eward, PE
    Glen, AIM
    Glen, ACA
    Macdonald, DJ
    Boyle, RM
    Horrobin, DF
    PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2000, 63 (1-2): : 37 - 39
  • [50] Nuclear membrane mechanotransduction by cytosolic phospholipase A2
    Niethammer, P.
    Shen, Z.
    Belcheva, K. T.
    Jelcic, M.
    Hui, K.
    Katikaneni, A.
    MOLECULAR BIOLOGY OF THE CELL, 2023, 34 (02) : 99 - 99